Prozkoumejte nejčtenější články a videa na Campus Sanofi
Reduction in kidney function decline and risk of severe clinical events in Agalsidase beta–treated Fabry disease patients: a matched analysis from the Fabry Registry Batista JL, et al. Clin Kidney J. 2024;17(8):sfae194.
A series of short videos with Prof. Hermans, Head of the Division of Haematology, the Thrombosis Unit as well as the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium.